ID

27602

Description

Effect of ACE-inhibitors on Aortic Stiffness in Elderly Patients With Chronic Kidney Disease; ODM derived from: https://clinicaltrials.gov/show/NCT00874432

Lien

https://clinicaltrials.gov/show/NCT00874432

Mots-clés

  1. 21/11/2017 21/11/2017 -
Détendeur de droits

See clinicaltrials.gov

Téléchargé le

21 novembre 2017

DOI

Pour une demande vous connecter.

Licence

Creative Commons BY 4.0

Modèle Commentaires :

Ici, vous pouvez faire des commentaires sur le modèle. À partir des bulles de texte, vous pouvez laisser des commentaires spécifiques sur les groupes Item et les Item.

Groupe Item commentaires pour :

Item commentaires pour :

Vous devez être connecté pour pouvoir télécharger des formulaires. Veuillez vous connecter ou s’inscrire gratuitement.

Eligibility Cardiovascular Disease NCT00874432

Eligibility Cardiovascular Disease NCT00874432

Inclusion Criteria
Description

Inclusion Criteria

Alias
UMLS CUI
C1512693
age > 60 years
Description

Age

Type de données

boolean

Alias
UMLS CUI [1]
C0001779
bp 120/80 or higher *(bps will be checked weekly first 4 weeks to ensure < 130/80- if bp remains > 130/80 we will administer other bp meds per jnc vii guidelines)
Description

Blood Pressure

Type de données

boolean

Alias
UMLS CUI [1]
C0005823
ckd stage 3 (gfr 30 - 59 ml/min) for ckd group; no ckd for control group
Description

Chronic Kidney Disease stage | Glomerular Filtration Rate

Type de données

boolean

Alias
UMLS CUI [1,1]
C1561643
UMLS CUI [1,2]
C2074731
UMLS CUI [2]
C0017654
Exclusion Criteria
Description

Exclusion Criteria

Alias
UMLS CUI
C0680251
known significant cvd (history of mi, recurrent stroke, or nyha class iii or greater).
Description

Cardiovascular Diseases | Myocardial Infarction | Cerebrovascular accident Recurrent | New York Heart Association Classification

Type de données

boolean

Alias
UMLS CUI [1]
C0007222
UMLS CUI [2]
C0027051
UMLS CUI [3,1]
C0038454
UMLS CUI [3,2]
C2945760
UMLS CUI [4]
C1275491
serum potassium > 5.2 meq/l
Description

Serum potassium measurement

Type de données

boolean

Alias
UMLS CUI [1]
C0302353
known allergy or hypersensitivity to ace inhibitor or arb
Description

Angiotensin-converting-enzyme inhibitor allergy | Allergy to angiotensin II receptor antagonist

Type de données

boolean

Alias
UMLS CUI [1]
C0571939
UMLS CUI [2]
C2585204
female of childbearing age not practicing contraception
Description

Childbearing Potential Contraceptive methods Lacking

Type de données

boolean

Alias
UMLS CUI [1,1]
C3831118
UMLS CUI [1,2]
C0700589
UMLS CUI [1,3]
C0332268
current treatment with an ace-i or arb (note: can participate if on ace-i after 6 week washout period)
Description

Angiotensin-Converting Enzyme Inhibitors | Angiotensin II receptor antagonist

Type de données

boolean

Alias
UMLS CUI [1]
C0003015
UMLS CUI [2]
C0521942
history of ace-i induced angioedema
Description

Angioedema ACE-I induced

Type de données

boolean

Alias
UMLS CUI [1,1]
C0002994
UMLS CUI [1,2]
C0003015
UMLS CUI [1,3]
C0205263
history of angioedema, hereditary or idiopathic
Description

Angioedemas, Hereditary | Idiopathic angioedema

Type de données

boolean

Alias
UMLS CUI [1]
C0019243
UMLS CUI [2]
C1304177
persons lacking consent capacity
Description

Informed Consent Unable

Type de données

boolean

Alias
UMLS CUI [1,1]
C0021430
UMLS CUI [1,2]
C1299582
500 mg/dl proteinuria on 2 consecutive spot urine protein/creat ratios
Description

Proteinuria | Urine protein/creatinine ratio measurement Quantity

Type de données

boolean

Alias
UMLS CUI [1]
C0033687
UMLS CUI [2,1]
C1096054
UMLS CUI [2,2]
C1265611

Similar models

Eligibility Cardiovascular Disease NCT00874432

Name
Type
Description | Question | Decode (Coded Value)
Type de données
Alias
Item Group
C1512693 (UMLS CUI)
Age
Item
age > 60 years
boolean
C0001779 (UMLS CUI [1])
Blood Pressure
Item
bp 120/80 or higher *(bps will be checked weekly first 4 weeks to ensure < 130/80- if bp remains > 130/80 we will administer other bp meds per jnc vii guidelines)
boolean
C0005823 (UMLS CUI [1])
Chronic Kidney Disease stage | Glomerular Filtration Rate
Item
ckd stage 3 (gfr 30 - 59 ml/min) for ckd group; no ckd for control group
boolean
C1561643 (UMLS CUI [1,1])
C2074731 (UMLS CUI [1,2])
C0017654 (UMLS CUI [2])
Item Group
C0680251 (UMLS CUI)
Cardiovascular Diseases | Myocardial Infarction | Cerebrovascular accident Recurrent | New York Heart Association Classification
Item
known significant cvd (history of mi, recurrent stroke, or nyha class iii or greater).
boolean
C0007222 (UMLS CUI [1])
C0027051 (UMLS CUI [2])
C0038454 (UMLS CUI [3,1])
C2945760 (UMLS CUI [3,2])
C1275491 (UMLS CUI [4])
Serum potassium measurement
Item
serum potassium > 5.2 meq/l
boolean
C0302353 (UMLS CUI [1])
Angiotensin-converting-enzyme inhibitor allergy | Allergy to angiotensin II receptor antagonist
Item
known allergy or hypersensitivity to ace inhibitor or arb
boolean
C0571939 (UMLS CUI [1])
C2585204 (UMLS CUI [2])
Childbearing Potential Contraceptive methods Lacking
Item
female of childbearing age not practicing contraception
boolean
C3831118 (UMLS CUI [1,1])
C0700589 (UMLS CUI [1,2])
C0332268 (UMLS CUI [1,3])
Angiotensin-Converting Enzyme Inhibitors | Angiotensin II receptor antagonist
Item
current treatment with an ace-i or arb (note: can participate if on ace-i after 6 week washout period)
boolean
C0003015 (UMLS CUI [1])
C0521942 (UMLS CUI [2])
Angioedema ACE-I induced
Item
history of ace-i induced angioedema
boolean
C0002994 (UMLS CUI [1,1])
C0003015 (UMLS CUI [1,2])
C0205263 (UMLS CUI [1,3])
Angioedemas, Hereditary | Idiopathic angioedema
Item
history of angioedema, hereditary or idiopathic
boolean
C0019243 (UMLS CUI [1])
C1304177 (UMLS CUI [2])
Informed Consent Unable
Item
persons lacking consent capacity
boolean
C0021430 (UMLS CUI [1,1])
C1299582 (UMLS CUI [1,2])
Proteinuria | Urine protein/creatinine ratio measurement Quantity
Item
500 mg/dl proteinuria on 2 consecutive spot urine protein/creat ratios
boolean
C0033687 (UMLS CUI [1])
C1096054 (UMLS CUI [2,1])
C1265611 (UMLS CUI [2,2])

Utilisez ce formulaire pour les retours, les questions et les améliorations suggérées.

Les champs marqués d’un * sont obligatoires.

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial